文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

血清尿酸、痛风与新发脓毒症的关联:一项基于英国生物银行的大型人群前瞻性队列研究

Association of serum uric acid, gout with incident sepsis: a large population-based prospective cohort study from UK Biobank.
PubMed 文献 · J Intensive Care · 2026-08-28
一句话结论在UK Biobank队列中,无症状高尿酸血症和痛风与新发脓毒症风险升高相关(HR分别为1.31和1.35),且无症状高尿酸血症与脓毒症患者28天死亡率轻度升高相关。

该研究基于UK Biobank前瞻性队列,纳入466,611名参与者,中位随访14.53年,采用多变量Cox模型分析临床尿酸表型(正常尿酸、无症状高尿酸血症、痛风)与新发脓毒症的关联。结果显示,与正常尿酸组相比,无症状高尿酸血症和痛风患者脓毒症风险分别升高31%和35%;SUA四分位组脓毒症风险逐级升高,Q4相对Q1的HR为1.27;限制性立方样条显示SUA与脓毒症风险呈非线性关联,约384.8 μmol/L以上风险增加。在脓毒症患者中,无症状高尿酸血症与28天全因死亡率升高相关(HR 1.17),而基线痛风与死亡率关联经调整后不显著。

要点

  • 在UK Biobank 466,611名参与者中,无症状高尿酸血症者新发脓毒症风险较正常尿酸组升高(HR 1.31,95%CI 1.26-1.36)。
  • 痛风患者新发脓毒症风险亦升高(HR 1.35,95%CI 1.25-1.46),与无症状高尿酸血症幅度相近。
  • SUA与脓毒症风险呈非线性关联,约384.8 μmol/L以上风险逐渐增加(非线性P<0.001)。
  • 脓毒症患者中,无症状高尿酸血症与28天全因死亡率升高相关(HR 1.17,95%CI 1.07-1.29),痛风则无显著关联。
  • 该研究为观察性队列,提示尿酸表型可能有助于识别脓毒症易感人群,但不能推断因果关系。

适用人群与场景

  • UK Biobank前瞻性队列的466,611名参与者,中位随访14.53年。
  • 暴露分组为临床尿酸表型:正常尿酸、无症状高尿酸血症、痛风;另按SUA四分位及单独HUA和痛风状态分析。

诊断标准与关键阈值

  • 临床尿酸表型分为正常尿酸、无症状高尿酸血症(asymptomatic HUA)和痛风(gout)。
  • SUA与脓毒症风险的非线性关联中,风险约在384.8 μmol/L以上增加(限制性立方样条分析)。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:基于UK Biobank的前瞻性队列分析,样本量466,611人,中位随访14.53年,发生16,210例新发脓毒症。
  • 与正常尿酸组相比,无症状高尿酸血症和痛风患者新发脓毒症风险升高,全调整HR分别为1.31(95%CI 1.26-1.36;P<0.001)和1.35(95%CI 1.25-1.46;P<0.001)。
  • SUA四分位分析:以Q1为参照,Q2、Q3、Q4的新发脓毒症HR分别为1.06(95%CI 1.01-1.12)、1.12(95%CI 1.07-1.19)、1.27(95%CI 1.20-1.34)。
  • 限制性立方样条显示SUA与新发脓毒症风险呈非线性关联(P<0.001;非线性P<0.001),风险约在384.8 μmol/L以上增加。
  • 脓毒症患者28天全因死亡率:无症状高尿酸血症在全调整模型中与较高风险相关(HR 1.17,95%CI 1.07-1.29,P<0.01);基线痛风经调整后关联不显著。

证据类型、等级与局限

  • 证据类型:基于UK Biobank的前瞻性观察性队列研究。
  • 局限:观察性设计不能推断因果关系;原文未提及单中心、回顾性、开放标签或样本量小等局限。

对床旁实践的改变

  • 该研究提示无症状高尿酸血症和痛风患者新发脓毒症风险较高,可能有助于识别脓毒症易感人群,但为观察性关联,不能据此改变急诊或ICU的常规筛查或治疗。
  • 脓毒症患者中,无症状高尿酸血症与28天全因死亡率轻度升高相关,但原文未提供基于尿酸水平的干预措施,不能作为治疗阈值。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Sepsis remains a major cause of morbidity and mortality, yet current strategies for identifying susceptible individuals provide limited discriminatory performance. Although serum uric acid (SUA) and gout have been implicated in inflammatory and immune dysregulation, the associations of clinical urate phenotypes with incident sepsis risk and prognosis remain incompletely understood.

METHODS: A prospective cohort analysis was conducted using UK Biobank data including 466,611 participants, in which clinical urate phenotypes (normal uric acid, asymptomatic HUA, and gout) were evaluated as primary exposures, with SUA quartiles and separate HUA and gout status analyses used as alternative exposure definitions, using multivariable Cox proportional hazards models, restricted cubic spline analyses, subgroup analyses, and sensitivity analyses including Fine-Gray competing-risk models.

RESULTS: During a median follow-up of 14.53 years, 16,210 incident sepsis cases were identified. Compared with the normal uric acid group, asymptomatic HUA and gout were associated with higher sepsis risk after full adjustment, with HRs of 1.31 (95% CI 1.26-1.36; P < 0.001) and 1.35 (95% CI 1.25-1.46; P < 0.001), respectively. Sepsis risk increased progressively across SUA quartiles, with HRs of 1.06 (95% CI 1.01-1.12), 1.12 (95% CI 1.07-1.19), and 1.27 (95% CI 1.20-1.34) for Q2, Q3, and Q4 relative to Q1, respectively. Restricted cubic spline analysis shown a nonlinear association between SUA and sepsis risk (P < 0.001; P for nonlinearity < 0.001), with risk increasing above approximately 384.8 μmol/L. For 28-day all-cause mortality among sepsis patients, asymptomatic HUA remained associated with a higher risk in the fully adjusted model (HR 1.17, 95% CI 1.07-1.29, P < 0.01), whereas the association for baseline gout was not significant after adjustment.

CONCLUSION: Higher SUA levels, HUA, and gout were associated with a higher incidence of sepsis in this observational cohort. Among patients who developed sepsis, asymptomatic HUA was associated with modestly higher short-term mortality, whereas this risk was not observed in the gout group.

来源:J Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Han Y, Zhang Y, Chen C, et al. Association of serum uric acid, gout with incident sepsis: a large population-based prospective cohort study from UK Biobank. J Intensive Care. 2026. PMID: 42665837. doi:10.1186/s40560-026-00925-z

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。